It is shown that recycling endosomal pH, controlled in part by the NHE6 exchanger NHE6, is a previously unrecognized determinant of KCC2 trafficking, which bridges two physiological processes, endosomal trafficking and inhibitory neuronal plasticity, and identifies a cellular checkpoint that could explain why endosomal disorders so often produce epilepsy.
The divergence between morphological, electrophysiological and transcriptomic findings suggests that compensatory mechanisms may contribute to network hyperexcitability, and the graded severity of network alterations across STX1B variants correlates with the clinical phenotypes.
Carolin Haag, Felix Gsell, Oleg Vinogradov et al.· EBioMedicine· 0 citations
This review synthesizes recent genetic, molecular, cellular and preclinical evidence on CNTNAP2 function and dysfunction across the neurodevelopmental spectrum from highly penetrant recessive disorder to common autism spectrum disorder risk variation with the focus on human-specific expression patterns, mechanistic con...
Arpan Dhungel, Rinchi Bora, A. Chamidah et al.· Molecular and cellular neuro...· 0 citations
Significant upregulations in brain-derived neurotrophic factor (BDNF) and the immediate early transcription factor, early growth response-3 (EGR3), which is necessary for the induction of BDNF following electroconvulsive seizures were revealed.
A. Mazumder, Saifina Karedia, Nandani Adhyapak et al.· Brain : a journal of neurolo...· 1 citation
The highly polarised morphology of neurons and the sheer length of their axons make transport of cargoes throughout the cell a formidable task. Decades of evidence obtained from genetic studies on patients and animal models highlight deficits in axonal transport as a recurrent cause, or early contributing factor, in a...
David Villarroel-Campos, J. N. Sleigh· Cytoskeleton· 0 citations
The first comprehensive human mechanistic model of PPP1R9A haploinsufficiency using an isogenic CRISPR/Cas9-engineered iPSC system differentiated into cortical neurons is established, providing a human-specific mechanistic framework linking reduced Neurabin I dosage to neurodevelopmental and psychiatric disease risk.
The use of an adenine base editor (ABE) to directly correct SCN1AR613X, a recurrent variant found in patients with DS, suggests the therapeutic potential of prime editing for the treatment of patients with SCN1A-associated GEFS+.
Samantha A Dow, Tracy A. Bedrosian· Epilepsy Currents· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.